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CLINICAL INVESTIGATION
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Renal TGF-j3 in HIV-associated kidney diseases. Human immunodefi-
ciency virus (HIV)-1 infection may be complicated by progressive renal
glomerular disease, including focal segmental glomerulosclerosis (FSGS)
and proliferative glomerulonephritis. We examined renal tissue from 71
patients, including biopsies and autopsies from patients in the presence
and absence of HIV-1 infection. We assessed the extent of TGF-13,
interstitial fibrosis, and interstitial CD45-positive cellular infiltrate using
immunohistochemistry. Extracellular TGF-pl/133 was largely confined to
the renal interstitium, with the highest scores in HIV-seropositive renal
disease and crescentic nephritis. Among all biopsies, the TGF-131/p3 score
correlated with the fibrosis score (r = 0.79,P < 0.0001) and with the CD45
score (r = 0.60, P < 0.0001). Biopsies from HIV-infected patients, taken
together, showed marginally more TGF-131/133 compared to biopsies from
HIV-uninfected patients (P = 0.05); similarly, HIV-associated FSGS
showed marginally more TGF-/31/133 compared to FSGS biopsies obtained
from HIV-uninfected patients (P 0.05). Intracellular TGF-/31 and
TGF-f33 were both expressed by renal tubular epithelial cells and in
extraglomerular crescents, whereas TGF-f33 was also present within
interstitial mononuclear cells and eosinophils, and, exclusively in HIV-
infected patients, within glomerular cells. In conclusion, TGF-f3 expres-
sion was increased in several progressive glomerular diseases, and was
particularly but not uniquely elevated in HI V-associated renal diseases.
Approximately 10% of patients infected with human immuno-
deficiency virus (HIV)-1 develop a syndrome characterized by
proteinuria, often with nephrotic syndrome, and progressive renal
dysfunction [reviewed in 1, 2]. The most common histologic
patterns seen in HI V-infected patients with chronic renal disease
is focal segmental glomerulosclerosis (FSGS), microcystic tubular
dilation, interstitial inflammatory infiltrate, tubuloreticular struc-
tures within glomerular endothelial cells detected by electron
microscopy, and varying degrees of glomerular collapse. This
entity has been termed HI V-associated nephropathy. Proliferative
glomerulonephritis is also associated with HIV infection, includ-
ing mesangial proliferative glomerulonephritis, IgA nephropathy
[3, I and immune complex glomcrulonephritis [5].
HIV-l infection is associated with increased production of
TGF-f31. Monocytes from HIV-1 infected patients produce in-
creased amounts of TGF-pl in vitro [6], and increased expression
of TGF-131 within the central nervous system has been linked to
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HIV-associated neurologic dysfunction [7]. Recently, the HIV-1
transactivating protein Tat has been shown to increase release of
TGF-f31 from bone marrow macrophages [8], suggesting that
HIV-1 proteins without viral infection can alter cytokine expres-
sion. Evidence that similar mechanisms may contribute to HIV-
associated nephropathy comes from HIV-transgenic mice, in
which progressive renal disease is associated with increased renal
tubular cell expression of TGF-131 and -f33 [9].
Evidence from studies in human patients [10—12] and experi-
mental animals suggests that renal TGF-131 expression is in-
creased in progressive renal disease. Increased glomerular accu-
mulation of TGF-/31 has been reported in rat anti-thymocyte
serum nephritis [13, 14], rat streptozotocin diabetes [151 and
rabbit anti-glomerular basement membrane disease [16]. In-
creased tubular epithelial cell expression of TGF-pl has been
seen following unilateral ureteral ligation [17] and in HIV-
transgenic mice [9], and interstitial fibroblasts increase expression
of TGF-pl in multiple-dose anti-thymocyte serum nephritis [10].
The present studies were designed to examine whether progres-
sive renal disease, and particularly that associated with HIV-1
infection, is associated with increased accumulation of TGF-J31 or
TGF-f33 within the kidney. We studied renal tissue obtained by
biopsy or at autopsy from patients infected with HIV-1, together
with similar material obtained from HIV-uninfected patients with
and without renal disease. We find increased expression of TGF-13
in renal biopsies from HIV-seropositive patients, both those with
FSGS and those with other glomerular lesions, as well as in renal
tissue from patients with glomerular disease in the absence of
HIV-1 infection. Low expression of TGF-J3 was seen in most
autopsy cases in the absence of glomerular disease, both in
patients with and without HIV infection.
Methods
Patient material
Formalin-fixcd, paraffin-embedded kidney tissue was available
from renal biopsies obtained from 51 patients, including 16
HIV-infected patients and 35 patients without risk factors for or
serologic evidence of HIV-1 infection (Table 1). We selected
biopsies for study so as to include a range of inflammatory and
non-inflammatory renal diseases that occur in our population,
together with patients with thin basement membrane disease to
serve as a non-inflammatory control group. We included only
biopsies with a minimum of 3 glomeruli, and most biopsies had
more than 10 glomeruli. HIV-associated FSGS (group 1) was
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Table 1. Patient characteristics
Race
Group Diagnosis N
Gender
(M/F)
(W/B/
A)
I HIV+ FSGS 9 9/0 0/9/0
2 HIV+ glomerulonephritis 7 6/1 3/4/0
3 crescentic glomerulonephritis 5 3/2 3/1/1
4 lupus nephritis 8 2/6 2/5/15 membranous nephropathy 6 3/3 3/3/0
6 idiopathic FSGS 8 2/6 2/6/0
7 IgA nephropathy 5 3/2 3/1/1
8 thin basement membrane disease 3 1/2 1/1/1
9 HIV+ autopsy 12 12/0 8/4/0
10 HIV— autopsy
All patients
8
71
8/0
49/22
3/5/0
28/39/4
Kidney tissue was obtained by percutaneous renal biopsy (groups 1-7)
or at autopsy (groups 9—b). Patients in groups 1 and 2 were HI V-infected,
and those in groups 3—8 and 10 were uninfected. Abbreviations are: FSGS,
focal segmental glomeruloscierosis; M, male; F, female; W, white; B,
black; A, Asian.
present in 9 biopsies. HIV-associated glomerulonephritis (group
2) was present in 7 biopsies; these included four patients with
proliferative glomerulonephritis, two patients with IgA nephrop-
athy, of whom one had extraglomerular crescents, and one patient
with membranoproliferative glomerulonephritis. Among the 35
renal biopsies from HIV-negative patients, five patients had
crescentic glomerulonephritis (group 3, 1 patient each with IgA
nephropathy, diffuse proliferative lupus nephritis, Wegener's
granulomatosis, multiple myeloma with , light chain deposition
disease, and idiopathic rapidly progressive glomerulonephritis),
eight patients had lupus nephritis (group 4), six patients had
membranous glomerulonephritis (group 5), eight patients had
idiopathic FSGS (group 6), five patients had IgA nephropathy(group 7), and three patients had thin basement membrane
disease (benign familial hematuria, group 8).
Formalin-fixed, paraffin-embedded tissue was examined from
20 autopsies, including 12 HIV-infected patients and 8 HIV-
uninfected patients (Fig. 1). Among 12 autopsies on HIV-infected
patients (group 9), renal abnormalities were present in eight
patients, including one patient with cytomegaloviral infection, one
patient with Mycobacterium avium-intracellulare complex (MA!)
renal infection, three patients with Cryptococcus neoforinans
pyelonephritis, one patient with Candida albicans pyelonephritis,
one patient with Staphylococcus aureus renal microabscesses
complicating sepsis, and one patient with B cell lymphoma and
associated tubulointerstitial nephritis. No patient had FSGS or
glomerulonephritis; four patients had no histologic evidence of
kidney disease. Autopsies from eight HIV-uninfected patients
without renal disease (group 10) provided control tissue. Included
in this group were five patients dying of trauma and one patient
each with myocardial infarction, idiopathic cardiomyopathy, and
septic shock. The extent of interstitial fibrosis was evaluated on
Masson trichrome-stained sections.
Immunohistochemistty
Paraffin sections were cut at 3 m, deparaffinized and rehy-
drated. Endogenous peroxidase activity was blocked by treating
with 3% H202 in 40% methanol for 10 minutes. Immunostaining
was performed with a commercial streptavidin-hiotin-peroxidase
complex kit (Dako, Carpenteria, CA, USA). The peroxidase
substrate chromagen was aminoethylcarbazole. Sections were
counterstained with hematoxylin.
For detection of TGF-j3, sections were digested with 0.1%
hyaluronidase (Sigma, St. Louis, MO, USA) in 0.1 M sodium
acetate, 0.15 M sodium chloride, pH 5.5 for 30 minutes at 37°C.
The following polyclonal rabbit antibodies were used: (1) TGF-
f31/f33 (termed CC), raised against residues 1-30 of mature
TGF-131; this antibody has been shown to recognize both TGF-/31
and TGF-133 on Western blotting and recognizes extracellular but
not intracellular TGF-/3 [18]; (2) intracellular TGF-131 (termed
LC), raised against residues 1-30 of mature TGF-J31; (3) intracel-
lular TGF-/32, raised against residues 56-75 of human TGF-132
[19]; and (4) intracellular TGF-f33, raised against residues 50-60
of human TGF-/33 [20].
The specificities of the LC, anti-TGF-f32, and anti-TGF-3
antibodies in immunostaining have been previously demonstrated
by elimination of staining when the incubations are performed in
the presence of immunogenic peptide [18]. The CC antibody does
not recognize TGF-/3 in solution. Specificity has been previously
demonstrated by showing: (1) reduced staining when the CC
antibody titer was depleted by preincubation with recombinant
TGF-f31; and (2) that in fibrotic human colon carcinoma tissue,
CC staining is limited to discrete areas of extracellular matrix and
distributes quite differently from the staining for fibronectin [18].
In order to further demonstrate antibody specificity on the human
renal biopsy tissues used in the present study, we incubated the
CC antibody (12 j.g/ml) with human kidney tissue (Fig. 2A),
normal rabbit IgG (Zymed at 2 jg/ml; Fig. 2B), CC antibody
incubated with native Sepharose (Pharmacia, Piscataway, NJ,
USA; Fig. 2C), and CC antibody incubated with Sepharose
conjugated to recombinant human TGF-f31 (R&D Systems, Min-
neapolis, MN, USA). We found abundant staining of the extra-
cellular matrix within the fibrotic renal interstitium with the CC
antibody, which was absent with normal immunoglobulin and
greatly diminished following absorption with TGF-1-Sepharose.
These data confirm antibody specificity in immunlocalization of
TGF-13 in human renal tissue.
Purified IgG fractions were diluted in phosphate-buffered sa-
line (PBS) supplemented with 1% bovine serum albumin and
applied to the sections overnight at 4°C. Sections from all 73
patients were immunostained with antibody against TGF-/31//33.
Immunostaining with antibodies against TGF-f31 and TGF-f33 was
carried out on sections from 40 biopsies (group 1, 7/9; group 2,
7/9; group 3, 5/5; group 4, 7/8; group 5, 3/5; group 6, 5/8; group 7,
4/5; group 8, 2/3) and from 7 autopsies (group 9, 6/12; group 10,
1/8).
For identification of inflammatosy cells, mouse monoclonal
anti-CD45 (leukocyte common antigen; Dako), was diluted in
PBS to 3.7 g/ml and applied for 60 minutes at room temperature.
In some cases, further analysis of leukocyte subsets was performed
using antibodies against CD45RO (UCHL1; Dako; used at 3.0
itg/ml), OPD4 (Dako; used at 3.7 g/ml), and CD68 (PG-Mi;
Dako; used at 3.6 .tg/ml). CD45 is present on all lymphocytes and
some macrophages [21], CD45RO is expressed on most T lym-
phocytes [22], OPD4 is restricted to helper/inducer CD4-positive
T cells and is present on most of these cells [231, and CD68 is
present on all macrophages [24].
The number of CD45-positive inflammatory cells within the
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interstitium, the degree of TGF-p staining within the interstitium,
and the degree of interstitial fibrosis were rated on a semiquan-
titative scale, by one observer (lB.), who was unaware of the
identity of the tissues. The biopsies were scored as 0 to 4 in order
of increasing infiltrating cell number, with 0 representing absent
infiltrating cells, I representing focal sparse infiltrate, 2 represent-
ing focal moderate infiltrate, 3 representing diffuse moderate
infiltrate, and 4 representing diffuse severe infiltrate. TGF-f3
staining and interstitial fibrosis were rated 0 to 4, with 0 repre-
senting absent, 1 representing focal minimal staining, 2 represent-
ing focal moderate staining, 3 representing diffuse moderate or
focal intense staining, and 4 representing diffuse intense staining.
The kidney biopsies from patients with lupus nephritis were also
classified according to the WHO criteria [25].
Statistical analysis
We performed the non-parametric Kruskal-Wallis test with the
Tukey correction for multiple comparisons to determine whether
there were any differences among the original diagnostic catego-
ries (groups I to 9) with respect to three outcomes: expression of
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Fig. 1. Interstitial TGF-f3, fibrosis, and CD45 scores. The extent of
extracellular TGF-/31/3 staining in renal interstitium (A),
interstitial fibrosis (B), and CD45-positive leukocytes (C) in the
renal interstitium were scored. In these boxplots, the box
represents data points between the 25th and 75th percentiles, the
crossed bars represent the extent of the main body of the data,
with the exception of data outliers which are denoted by open
circles (0) and extreme data outliers that are denoted by filled
circles (•). Patient groups are as described in Table 1 (TBM, thin
basement membrane disease). In D, the mean and SD for each
histologic score are given by group. Non-parametric analysis
indicated that the groups were non-homogeneous (for TGF-j3,
fibrosis, and CD45 scores, P 0.001). For each group, all other
groups which differed significantly are given in parentheses.
D TGF-/3 Fibrosis CD45
Group Score Signif. Score Signif. Score Signif.
t HIV+ FSGS 2.3 1.2 (vs 7—10) 2.4 0.6 (vs 7—10) 2.6 0.9 (vs 7, 8, 10)
2 HIV+ GN 2.1 1.2 (vs 9, 10) 1.8 0.9 (vs 7—10) 2.7 1.1 (vs 7, 8, 10)
3 Crescentic GN 3.1 0.3 (vs 7—10) 3.2 0.3 (vs 5, 7—10) 1.8 0.9 (vs 10)
4 lupus nephritis 1.9 0.9 (vs 9, 10) 1.9 0.8 (vs 7—10) 1.9 0.8 (vs 6, 7, 8, 9)
5 memb. neph. 1.6 0.6 (vs 10) 1.4 0.5 (vs 8, 10) 1.4 0.7
6 idiop. FSGS 1.3 0.5 (vs 10) 1.7 0.8 (vs 7—10) 1.3 0.6 (vs 1—3)
7 IgA neph. 0.7 1.6 (vs 1, 3) 0.7 1.6 (vs 1—4, 6) 0.6 1.3 (vs 1—3)
8 TBM 0.2 0.3 (vs 1, 3) 0.2 0.3 (vs 1—6) 1.7 0.3 (vs 1—3)
9 HIV+ autopsy 0.5 0.8 (vs 1—4) 0.6 0.2 (vs 1—4, 6) 1.7 0.9 (vs 10)
10 HIV— autopsy 0.0 0.0 (vs 1—6) 0.4 0.4 (vs 1—6) 0.4 0.7 (vs 1—4, 9)
All patients 1.3 1.2 1.1 1.1 1.6 1.2
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Fig. 2. Demonstration of antibody specificity. (A) TGF-f31/133 staining using the CC antibody shows intense interstitial reaction with fibrotic areas. (B)
When normal rabbit IgG is used as the primary antibody, there is no tissue staining. (C) When the CC antibody is incubated with Sepharose, TGF-131/p3
staining remains within the interstitium. (D) When the CC antibody is absorbed by incubation with Sepharose conjugated to TGF-f31, tissue staining
is greatly diminished.
extracellular TGF-(31/(33 (TGF-13 score), severity of fibrosis (fi-
brosis score), and severity of inflammatory infiltrate (CD45
score). In addition, we combined diagnostic categories to compare
broader diagnostic groups (all HIV-infected patients vs. other
patients), again using the Kruskal-Wallis test. To test for linear
associations between TGF-f3, fibrosis, and CD45 scores, we cal-
culated the nonparametric Spearman correlation coefficients.
Statistical analysis was performed using the SAS program (SAS,
Cary, NC, USA) and Data Desk program (Data Description,
Ithaca, NY, USA). We chose P < 0.05 as the level of significance
and we report the results as mean SD.
Results
Extracellular TGF-f31/J33
Immunolocalization of extracellular TGF-/31/f33 had certain
features common to all groups. Extracellular TGF-/311f33 was
present in the cortical interstitium of diseased kidneys, either
focally or diffusely, and was particularly intense in areas occupied
by fibrotic material. Glomerular staining was limited to segmen-
tally and globally sclerotic glomeruli; morphologically normal
glomeruli showed no staining. Fibrous and fibrocellular glomeru-
lar crescents and areas of periglomerular fibrosis showed intense
TGF-p11133 staining. Occasional staining was also seen within the
juxtaglomerular apparatus and Bowman's capsule.
All HIV-infected patient biopsies (groups 1 and 2) exhibited
interstitial nephritis. These biopsies also had among the greatest
amount of TGF-f31!f33 within the interstitium (Figs. 1 and 3 A, B,
C). There was, however, no significant correlation between the
CD45 score as a measure of inflammation and the TGF-p score in
these groups. Furthermore, three biopsies showed no immunore-
active TGF-p11J33 despite the presence of inflammation. For
comparison, we stained biopsies from HIV-uninfected patients
with both inflammatory and non-inflammatory glomerular dis-
eases. Patients with crescentic glomerulonephritis uniformly had
TGF-plIp3 within the interstitium (Fig. 3 E, F), to an extent even
greater than HIV-infected patients, and in some cases had
deposits within glomerular crescents as well (Fig. 3E). Other
forms of glomerulonephritis, including lupus nephritis, membra-
nous glomerulonephritis, and idiopathic FSGS (Fig. 3D), showed
intermediate extent of interstitial TGF-pl/p3. Two disorders, IgA
nephropathy and thin basement membrane disease, had minimal
levels of interstitial TGF-f31/j33 staining, detected in one patient in
each group. These patients underwent renal biopsy for hematuria,
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Fig. 3. Immunolocalization of extracellular TGF-131/133 in kidney. (A) TGF-/31/J33 staining using the CC antibody showed that TGF-j31/3 was present in
areas of periglomerular and interstitial fibrosis in the biopsy from an HIV-infected patient with FSGS; there is no intraglomerular staining (X80). (B)
Abundant TGF-1/3 staining was present within the interstitium in the biopsy from a HTV-infected patient with FSGS (X80). (C) In an HIV-infected
patient with proliferative glomerulonephritis, TGF-131/133 staining was present in the interstitium, within an area marked by inflammatory infiltrate and
fibrosis (x 100). (D) In an HIV-uninfected patient with idiopathic FSGS, sparse staining for TGF-pl/p3 was present in the interstitium and within an
area of periglomerular fibrosis (arrowhead); TGF-l/p3 was absent from the glomerulus itself (X50). (E) TGF-p1/3 staining was present within a
glomerular crescent (arrowhead) and interstitium in the biopsy from an HIV-uninfected patient with lupus nephritis. (F) TGF-131/133 was present within
the interstitium and an area of periglomerular fibrosis (arrowhead) in the renal biopsy from an HIV-uninfccted patient with IgA nephropathy.
and none had significant proteinuria, indicating minimal renal most medulla. Similar faint staining was observed in renal tissue from
inflammatory disease. most of the autopsy cases. In autopsies performed on HIV-infected
Renal tissue from autopsies performed on HIV-uninfected patients, focal TGF-131/133 staining was present in renal tissue from
individuals dying of trauma or of non-renal disease showed only 3/12 patients. TGF-/31/f33 and acid-fast bacilli co-localized to tubular
occasional faint extracellular TGF-/31/f33 staining within the inner- epithelial cells and interstitial foam cells in a patient with renal MAT
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Fig. 4. Immunolocalization of intracellular TGF-j31 and -133 in kidney. (A) Intracellular TGF-131 staining using the LC antibody showed TGF-f31 within
peripheral glomerular cells (arrowheads) and parietal glomerular epithelial cells (arrows) in an HIV-infected patient with IgA nephropathy (X250). (B)
Intracellular TGF-f31 staining within the cells of a glomerular crescent from a HIV-uninfected patient with light chain deposition disease (X120). (C)
TGF-131 staining within tubular epithelial cells (arrowheads) in renal tissue from an HI V-infected patient with IgA nephropathy (same patient as in A;
X200). (D) TGF-/31 staining within fibroblasts in renal tissue from an HIV-infected patient with IgA nephropathy (same patient as in A; X100). (E)
TGF-133 was localized to inflammatory cells (arrows) within the interstitium and intraglomerular cells (arrowhead) in an HI V-infected patient with
proliferative glomerulonephritis (x 60). (F) Higher magnification of the biopsy shown in (F), with intracellular TGF-133 located within mononuclear cells
(arrow) and binucleated leukocytes consistent with eosinophils (arrowheads) in the interstitium (X250).
infection. Focal extracellular TGF-/31/j33 staining was present in Relationship between extracellular TGF-f311p3, fibrosis, and CD45
the biopsy obtained from a patient with C. albicans infection, scores
localized to abscesses with fibrosis, but was absent from acute
abscesses without fibrosis. Similarly, extracellular TGF-/31/133 Analysis of data from all 71 patiets showed a signfficant positive
staining was present in the biopsy from a patient with staphylo- correlation between fibrosis score and the interstitial TGF-f31//33
coccal sepsis, within macrophages adjacent to microabscesses. score (r = 0.79, P < 0.0001). There was a somewhat weaker
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Table 2. Linear correlations of leukocyte subsets with TGF-/3 immunostaining and fibrosis scores in kidney tissue from HIV-infected patients
Group Diagnosis N vs. TGF-/3 P vs. Fibrosis P N vs. TGF-/3 P vs. Fibrosis P N vs. TGF-/3 P vs. Fibrosis P
I HIV+ FSGS 8 0.15 NS 0.24 NS 8 —0.27 NS 0.20 NS 8 —0.28 NS 0.04 NS
2 HIV+ GN 7 0.17 NS 0.85 <0.004 7 —0.10 NS 0.71 <0.04 7 0.16 NS 0.79 0.01
8 HIV+ autopsy 10 0.03 NS 0.14 NS ND ND 11 0.55 NS —0.14 NS
correlation between fibrosis score and CD45 score (r = 0.70,P <
0.0001) and between the CD45 score and the TGF-/31/f33 score(r = 0.60, P < 0.0001). When these relationships were examined
within each patient group, there was strong positive correlation
between the presence of an inflammatory infiltrate and the extent
of extracellular TGF-/31//33 staining (r = 0.85, P = 0.007) only in
patients with lupus nephritis; the other correlations were not
significant. In this group, there was no correlation between these
scores and the glomerular pathology as reflected in the WHO
class.
Next, we compared biopsy material from patients with and
without HIV-1 infection, omitting for this analysis autopsy mate-
rial due to the absence of progressive renal disease in this
population. HIV-1 infection was associated with increased CD45
score (2.7 0.9 vs. 1.4 1.1, = 11.3, P = 0.0008) and
borderline increased TGF-/31/f33 score (2.2 1.2 vs. 1.5 1.1 x2
= 73.8, P = 0.05), while the fibrosis score was not different
between infected and uninfected patients (2.2 0.8 vs. 1.6 1.1,
= 2.8, P = 0.09). Finally, we compared biopsies showing FSGS
from HIV-infected and uninfected patients, and found that HIV-
associated FSGS was characterized by higher CD45 scores (2.6
0.9 vs. 1.3 0.6, = 7.8, P = 0.005) and borderline increased
TGF-f31/133 score (2.3 1.2 vs. 1.3 0.5 x2 = 4.0,P = 0.05), while
the fibrosis score was not different (2.4 0.6 vs. 1.7 0.8, =
3.3, P = 0.07).
Leukocyte subsets
Further analysis of leukocyte subsets was carried out on renal
tissue from HIV-infected patients, using antibodies against
CD45RO, OPD4, and CD68. Expression of these epitopes in
kidney was not correlated with extracellular TGF-/31/133 scores or
interstitial fibrosis scores in patients with HIV-associated FSGS or
in HIV-infected autopsy patients (Table 2). In HIV-infected
patients with glomerulonephritis, however, there were significant
correlations between interstitial fibrosis and CD45RO scores (r =
0.85, P < 0.0004), OPD4 scores (r = 0.71, P < 0.04), and
macrophage scores (r = 0.79,P = 0.01). On the other hand, there
was no correlation between extracellular TGF-131//33 scores and
these leukocyte subsets.
Intracellular TGF-f3 localization
To localize the cellular source of TGF-p staining, we used
TGF-/3 isoform-specific antibodies that detect intracellular
TGF-/3. TGF-/31 was localized to tubular epithelial cells, predom-
inantly of the distal tubule and collecting duct, to extraglomerular
crescents, and less commonly, to intraglomerular cells and inter-
stitial cells (Table 3). TGF-/33 showed a similar pattern, but with
additional localization to arteriolar walls and more frequent
Intracellular TGF-/31
HIV + FSGS
HIV + GN
HIV-infected
Crescentic GN
Lupus nephritis
Memb. nephropathy
Idiopathic FSGS
IgA nephropathy
TBM
HIV-uninfected
Intracellular TGF-/33
HIV + FSGS
HIV + GN
HIV-uninfected
Crescentic GN
Lupus nephropathy
Memb. nephropathy
Idiopathic FSGS
IgA nephropathy
TBM
HIV-uninfected
2/6
4/13
1/1
1/1
3/6
6/13
0/6
0/13
0/6
0/13
0/5
0/6
0/3
0/3
0/2
0/2
0/21
5/5
NA
NA
NA
NA
NA
5/5
5/5
4/6
1/3
1/3
2/2
0/2
13/21
0/5
0/6
0/3
0/3
0/2
0/2
0/21
0/5
0/6
0/3
0/3
0/2
0/2
0/21
2/7
3/6
5/13
NA
1/1
1/1
5/7
4/6
9/13
1/7
2/6
3/13
2/7
3/6
5/13
0/5
2/7
1/3
1/4
0/4
0/2
4/25
0/5
NA
NA
NA
NA
NA
0/5
5/5
6/7
2/3
3/4
1/4
0/2
17/25
5/5
2/7
1/3
1/4
1/4
0/2
10/25
2/5
6/7
0/3
2/4
1/4
0/2
11/25
The frequency of intracellular localization of TGF-!31 and -/33 in
particular renal compartments was assessed in available material from 38
biopsies. Abbreviation NA is not applicable; other abbreviations are in
Figure 1.
localization to interstitial mononuclear cells. TGF-/32 was re-
stricted to vessel walls in the four kidneys examined.
Intracellular TGF-p staining was notable in several respects.
First, intraglomerular TGF-J31 staining was present in only four
patients, all of whom were HIV-infected (2 patients in group 1
and 2 patients in group 2; Fig. 4A). By contrast, intraglomerular
TGF-133 staining was noted in several groups, including HIV-
associated FSGS (2/7), HIV-associated glomerulonephritis (3/6),
lupus nephritis (2/7), membranous nephropathy (1/3), and idio-
pathic FSGS (1/4), and was absent in other biopsies (0/6) and
autopsy tissue from HIV-infccted patients (0/6) and HIV-unin-
fected patients (0/1). Although the cells producing TGF-/31 and
-133 could not be conclusively identified, in many cases they
exhibited a peripheral glomerular location consistent with visceral
glomerular epithelial cells; positive cells appeared hypertrophic.
while normal-appearing glomerular epithelial cells failed to stain
for TGF-/3. An exception to this pattern was a predominantly
mesangial cell distribution of TGF-133 seen in one patient with
lupus nephritis. Second, extraglomerular crescents, when present
on the sections examined, consistently exhibited TGF-/31 (Fig.
4B). Third, renal tubules showed specific staining for both
T cells OPD4+ T cells Macrophages
The linear correlations between a semiquantitative evaluation of the numbers of CD45+ T cells, OPD4+ helper/inducer T cells, and CD68+
macrophages within the renal interstitium, and the interstitial TGF-f3 and fibrosis scores are presented, together with the statistical significance.
Abbreviations are: FSGS, focal segmental glomerulosclerosis; GN, glomerulonephritis; NS, not significant; ND, not determined.
Table 3. Intracellular localization of TGF-J3
Glomeruli Crescents Tubules Interstitium Vessels
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TGF-f31 (Fig. 4C) and TGF-133 in the majority of cases. The
proportion of each group exhibiting tubular staining was in
general comparable to the proportion of each group with extra-
cellular TGF-(3l/133 staining. When TGF-/31/(33 was present
within the interstitium, renal tubules showed either TGF-f31 or f33
in 30 cases and showed neither in the remaining 5 cases. On the
other hand, when TGF-/31/133 was absent from the interstitium,
TGF-f31 and/or TGF-133 was absent from the tubules in 5 cases
and present within tubules in the remaining 5 cases (of which 3
were from HI V-infected patient autopsies showing focal pyelone-
phritis, which may represent an acute process in which interstitial
accumulation of TGF-J3 has not occurred). Taken together, these
data suggest that in the chronic diseases which predominate in this
study, extracellular matrix-associated TGF-J31/f33 staining in gen-
eral parallels intracellular TGF-131 and/or TGF-/33 staining.
Fourth, interstitial cells stained frequently for TGF-j33 (13/36) but
not for TGF-p1 (0/34). The cell types positive for TGF-/33
included mononuclear inflammatory cells (11 cases, including all
5 patients with crescentic glomerulonephritis), binucleated leuko-
cytes compatible with eosinophils (9 cases, including 4/5 patients
with crescentic glomerulonephritis; Fig. 4 E, F), and large, stellate
cells suggestive of myofibroblasts (Fig. 4D). Fifth, the media of
arterioles and small arteries stained for TGF-p2 (4/4, data not
shown) and TGF-133 (16/38), but not TGF-31 (0/34).
Discussion
We have shown increased accumulation of TGF-p in several
renal diseases. The highest levels of expression of interstitial
TGF-/31/f33 were present in HIV-associated kidney diseases,
including FSGS and proliferative glomerulonephritis, and in
crescentic glomerulonephritis. Intermediate levels were present in
patients with lupus nephritis, membranous nephropathy, idio-
pathic FSGS, and IgA nephropathy. Minimal TGF-13 staining was
present in patients with thin basement membrane disease, a
non-progressive renal condition, and in autopsy material from
patients without kidney disease. We did not find substantially
increased interstitial accumulation of TGF-f3 in most kidneys
from HIV-infected patients dying without glomerular disease,
suggesting that the increase in interstitial TGF-/3 in HIV-associ-
ated nephropathy is associated with progressive renal disease and
not HIV-1 infection in the absence of kidney disease.
The TGF-131/f33 antibody (CC) used in the present study was
raised against a TGF-f31 peptide and recognizes both active
TGF-/31 and -f33. The amount of extracellular TGF-f3 present at
any given time represents the accumulation that results from an
imbalance between secretion and utilization and/or degradation.
Evaluation of extracellular TGF-f3 may provide information as to
the chronicity of the inflammatory process.
In the present study, interstitial TGF-(31/f33 scores correlated
significantly with the degree of interstitial fibrosis in the total
patient group (r = 0.72, P < 0.0001). These data would support a
role for TGF-13 in inducing interstitial fibrosis, as has been
suggested by numerous animal studies. An alternate explanation
would be that a fibrotic interstitium traps TGF-/3 and results in a
prolonged residence time in tissue without an increased produc-
tion of TGF-j3. Evidence against this interpretation includes the
observation that increased extracellular TGF-13 was usually seen
in parallel with increased intracellular TGF-/3. For individual
subgroups there was not a significant correlation between TGF-/3
scores and interstitial fibrosis, with the exception of IgA nephrop-
athy (r = 0.97, P < 0.002). The lack of correlation may be due to
the small number of patients in each subgroup or the narrow
range of scores provided by our semiquantitative rating system for
both TGF-f3 and fibrosis.
There was a significant correlation between interstitial inflam-
matory infiltrate, as assessed by the detection of CD45, which is
expressed on all leukocytes, and interstitial TGF-/3 expression in
the entire study population. Subgroup analysis, while limited by
sample size, suggested that this relationship was particularly
strong in biopsies from patients with lupus nephritis and IgA
nephropathy. Although these data only indicate an association, it
would be consistent with a model in which TGF-/3 accumulation
within the interstitium in these diseases is a direct or indirect
consequence of infiltrating inflammatory cells. On the other hand,
in other diseases, in particular HIV-related FSGS and idiopathic
FSGS, TGF-J3 expression by renal parenchymal cells may be
unrelated to the presence of mononuclear cells. We have similarly
shown a dissociation between the inflammatory cell number and
local tissue cytokine concentration in renal biopsies from HIV-
infected patients with FSGS and glomerulonephritis, suggesting
autocrine production of TGF-p by intrinsic renal cells [261.
When leukocyte subgroup analysis was performed on renal
tissue from HIV-infected patients with glomerular disease other
than FSGS, there was a significant correlation between the extent
of fibrosis and the number of infiltrating CD45RO-positive T cells
(r = 0.85, P < 0.004), OPD4+ helper/inducer T cells (r = 0.71,
P < 0.04), and CD68-positive macrophages (r = 0.79, P = 0.01).
On the other hand, there was no correlation between leukocyte
subsets and TGF-p expression in this patient group. These strong
correlations would support a role for infiltrating leukocytes in
producing fibrosis, but raise the possibility that the TGF-p is not
involved, or that the relationship to TGF-f3 is indirect. In renal
tissue from HIV-infected patients with FSGS, there was no
correlation between leukocyte subsets and either interstitial fibro-
sis or TGF-/3 score. These data suggest that the pathogenesis of
interstitial fibrosis in HIV-associated FSGS may be driven by
mechanisms other than leukocytic infiltration (such as direct
infection of parenchymal cells by HIV-1 or the action of circulat-
ing cytokines) or that the leukocytes critical to the fibrotic process
are not readily identified by these approaches.
Glomerular expression of intracellular TGF-J31 was seen exclu-
sively in HIV-infected patients, with no convincing staining in
other patients. Our results differ in some respects from those of
other investigators who have localized TGF-(31 in human kidney
tissue. Yamamoto et al, using the LC antibody, found glomerular
expression of TGF-f31 in diabetic nephropathy [151; we did not
study any patients with this disorder. Yoshioka et al, using an
antibody directed against TGF-J31, found minimal glomerular
staining in minimal change disease, mesangial proliferative ne-
phritis, and Henoch-Schönlein nephropathy [I1J. Significant mes-
angial staining was present in sclerotic glomeruli from patients
with IgA nephropathy and focal glomerulosclerosis, and also
membranous nephropathy, located along capillary walls. Mesan-
gial staining was also increased in all disorders following treat-
ment of the tissue sections with acid urea. We did not use this
tissue treatment, which may account for the different results.
Alternatively, there may be differences in antibody specificity or
the nature of the patient biopsies.
In the present study, glomerular expression of intracellular
TGF-(33 was present in both HIV-infected and HIV-uninfected
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patients with similar frequency. TGF-j33 has not been previously
localized in human kidney tissue. The identification of the gb-
merular cell types containing intracellular TGF-j3 cannot be made
conclusively based on the methods used in the present study,
although both glomerular epithelial arid mesangial cells appear to
contribute. Extraglomerular crescents, when present, were posi-
tive in all cases for both intracellular TGF-131 and -/33. The
presence of TGF-/3 in crescents may contribute to the fulminant
glomerular fibrosis and rapid loss of renal function that charac-
terizes crescentic glomerulonephritis.
Intracellular staining for TGF-f31 and -/33 was widespread
within tubular epithelial cells in patients from most groups. The
only groups in which such staining was never seen were patients
with benign familial hematuria and HIV-uninfected patient au-
topsies, two groups selected to serve as control groups since they
lack progressive renal disease. In 30 of 35 cases, renal tissue
exhibiting interstitial TGF-131/133 also showed tubular intracellular
TGF-f31 and/or -/33. This would support a role for the tubular
epithelial cell in producing or transporting TGF-13 into the
interstitium, where it may play a pathogenic role. It is likely that
tubular cell TGF-13 production is regulated by multiple factors,
possibly including other growth factors, monokines, and auto-
coids. Renal infection, by viruses or bacteria, may also stimulate
TGF-/3 production. In this context, it is noteworthy that MAT
organisms and TGF-p co-localized within renal tubular cells in
one patient. It has been previously shown that TGF-/3 contributes
to the pathogenicity of other intracellular pathogens, including
Tiypanosoma cruzi [271 and Leishmania braziliensis [28].
Interstitial cells expressed intracellular TGF-p3, and rarely,
TGF-131. Most frequently, these cells were mononuclear inflam-
matory cells, with a morphology consistent with monocyte/macro-
phages. Mononuclear cells expressing TGF-/33 were present in
HIV-associated glomerulonephritis and in patients with crescentic
glomerulonephritis, lupus nephritis, membranous nephropathy,
and IgA nephropathy, but were absent from HIV-associated
FSGS. Thus interstitial TGF-/3 may derive largely from the
tubular epithelium in HIV-infected patients with FSGS, while
interstitial TGF-/3 may derive from both the tubular epithelium
and interstitial mononuclear cells in HIV-infected patients with
glomerulonephritis. Other interstitial cells expressing TGF-p3
included myofibroblasts and binucleated leukocytes consistent
with eosinophils. Eosinophils from peripheral blood [29] and
tissues [30, 311 have been previously shown to produce TGF-J31,
although eosinophil expression of TGF-/3 in kidney has not
previously been shown and may represent an important mecha-
nism of chronic renal injury.
In conclusion, kidney tissue from patients with HIV-associated
renal diseases and crescentic glomerulonephritis showed the
greatest amount of immunoreactive TGF-p1/f33 within the renal
interstitium. Intermediate amounts of TGF-/31/p3 were present in
kidneys from patients with lupus riephritis, membranous nephrop-
athy, idiopathic FSGS, and IgA nephropathy. Interstitial TGF-
was also present in autopsy kidneys from HIV-positive
patients, but was absent or present in minimal amounts in patients
with thin basement membrane disease and HIV-uninfected pa-
tient autopsies. Biopsies from HIV-infected patients, taken to-
gether, showed marginally more TGF-/31//33 compared to biopsies
from HIV-uninfected patients (P = 0.05); similarly, biopsies with
HIV-associated FSGS showed marginally more TGF-/31/p3 com-
pared to FSGS biopsies obtained from HIV-uninfected patients
(P 0.05). Fibrosis scores were correlated with numbers of
infiltrating CD45-positive T cells, OPD4-positive T cells, and
CD68-positive macrophages in patients with HI V-associated gb-
merulonephritis, but not in patients with HIV-associated FSGS.
Further, interstitial leukocytes exhibited staining for intracellular
TGF-133 predominantly in patients with HIV-associated FSGS,
and crescentic glomerulonephritis and lupus nephritis in patients
without HIV-1 infection. These data would be consistent with a
role for infiltrating leukocytes in the pathogenesis of interstitial
fibrosis occurring in these disorders, while suggesting that TGF-/3
production in HIV-associated FSGS is independent of leukocyte
infiltration and may instead be a consequence of abnormalities of
the tubular epithelium induced by HIV-1.
The abundant expression of TGF-/3 within the interstitium of
patients with renal diseases with a high frequency of progression
to end-stage renal disease is compatible with a role in disease
progression, but it remains to be established whether TGF-/3 is a
marker or a contributory factor. Future studies will be required to
address whether the presence of TGF-/3 represents an indepen-
dent risk factor for progression to end-stage renal disease in
human patients.
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Note added in proof
Since the submission of this manuscript, a paper has been published
describing the expression of TGF-131, 2 and 3 isoforms in 53 cases of
human renal disease, exclusive of HIV-associated nephropathy
(YAMAMOTO T, NOBLE NA, NAST CC, HIsHIDA A, GOLD LI, BORDER WA:
Expression of transforming growth factor-p isoforms in human glomerular
disease. Kidney Int 49:461—469, 1996).
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